EKF Diagnostics (LON:EKF) Shares Pass Above 200-Day Moving Average of $28.64

EKF Diagnostics Holdings plc (LON:EKF)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 28.64 ($0.38) and traded as high as GBX 28.90 ($0.38). EKF Diagnostics shares last traded at GBX 27.45 ($0.36), with a volume of 167,898 shares.

EKF Diagnostics Price Performance

The stock has a market cap of £126.59 million, a price-to-earnings ratio of 2,745.00 and a beta of 0.61. The stock’s 50 day moving average price is GBX 28.45 and its two-hundred day moving average price is GBX 28.64. The company has a quick ratio of 1.77, a current ratio of 2.69 and a debt-to-equity ratio of 6.01.

EKF Diagnostics Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.